Realyze Intelligence’s Post

View organization page for Realyze Intelligence, graphic

747 followers

Meet Mel Mann, MBA, M.Ed - who, when diagnosed with terminal chronic myeloid leukemia (CML) in 1995, "saw a clinical trial as a chance to get tomorrow’s medicine today." Fast forward 26 years - Mel is a 26-year cancer survivor & is living proof of the life-changing power of clinical trials. He credits Dr. Druker and the life-saving drug he developed, Gleevec, for allowing him to see his daughter grow up and become a physician. At Realyze Intelligence, we harness clinician-trained-AI to empower cancer care sites to screen ALL patients for clinical trials that they may qualify for, ensuring more people like Mel can access cutting-edge treatments. We want patients to have more. More birthdays. More weddings. More graduations. More memories. More Mondays. Read more about Mel's Story https://lnkd.in/gtajzara #ClinicalTrials #CancerResearch #AIOncology #AIinPrecisionOncology #ClinicalTrialsForAll #NoMoreZombieTrials #RealyzeIntelligence

Mel's Story

Mel's Story

cancer.gov

Kathryn Doornbos

Science Minded 🤖 🧠 🦾 || Patient Centered 🤍

1mo

I'll always advocate for #MoreMondays 💙

Like
Reply

To view or add a comment, sign in

Explore topics